![Andre Pereira Fraga Figueiredo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andre Pereira Fraga Figueiredo
Direttore/Membro del Consiglio presso GENETETHER THERAPEUTICS INC.
Patrimonio netto: 64 077 $ in data 31/05/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
R. Geoffrey Sargent | M | 70 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 anni |
Daren Graham | M | 52 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 anni |
Garner William | M | 58 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 anni |
Roland Boivin | M | 57 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 anni |
Philip Jull | M | 64 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 anni |
Jean Jen | F | 37 |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Peter Sampson | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 7 | 100.00% |
Stati Uniti | 6 | 85.71% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Andre Pereira Fraga Figueiredo
- Contatti personali